Importance of Ethical Conduct and Participant Follow-Up in Clinical Trials                                                 

Clinical trials are the bedrock of medical progress, paving the way for life-saving drugs and treatments. But these trials rely on a delicate balance: scientific rigor and ethical principles. Protecting participants and ensuring their well-being is not just a moral imperative, it’s crucial for the validity of the research itself. Ethical conduct is the cornerstone […]

Breaking Down Barriers: Enhancing Participation in Clinical Trials

Clinical trials are the cornerstone of medical advancement. They allow us to test new drugs and treatments, refine existing ones, and ultimately, improve the lives of patients. However, participation in clinical trials is often low, due to a variety of barriers that can be challenging to overcome. In this blog, we will explore some of […]

Role of Clinical Trials in Propelling Medical Research Forward

In the dynamic realm of healthcare, clinical trials stand as the cornerstone of groundbreaking medical discoveries. These meticulously planned and executed studies play a pivotal role in advancing our understanding of diseases, testing innovative treatments, and ultimately improving patient outcomes. Driving Innovation: Clinical trials serve as the breeding ground for innovation in medicine. By testing […]

Exploring the vital partnership: monitor-investigator relationship in clinical trials

In the dynamic world of clinical trials, the collaboration between monitors and investigators plays a pivotal role in ensuring the success and integrity of research studies. This alliance is not just a procedural formality but a dynamic relationship that significantly influences the quality of data, adherence to protocols, and overall trial success. Understanding the Roles […]

Behind the Scenes of a Clinical Research Unit

Clinical research units (CRUs) play a pivotal role in advancing medical knowledge and developing new treatments for various diseases. These specialized units are often housed within hospitals, universities, or research institutions and bring together a diverse team of professionals dedicated to conducting clinical trials. The Heart of Clinical Research Clinical trials are carefully controlled studies […]

The Future of Clinical Research: Trends and Innovations to Watch

Clinical research, the backbone of medical advancements, is on the cusp of a revolution. With the rapid evolution of technology and an ever-growing understanding of human health, the way we conduct clinical trials and develop new therapies is undergoing a significant transformation. Here, we delve into the exciting trends and innovations shaping the future of […]

Zara Anjum Acing the Certified Clinical Research Professional Course at CTU-RMI

RMI is elated to share that Zara Anjum, our dedicated Clinical Research Associate of the Clinical Trials Unit (CTU), has achieved an outstanding feat by clinching the 1st position in the Certified Clinical Research Professional Training Course exam organized by Metrics Research. We extend our heartfelt congratulations to her for this well-deserved accomplishment. This achievement […]

AIMS Biosciences Project Manager Visits RMI CTU

AIMS Biosciences Project Manager Visits RMI CTU Chen Xhin Hui, Project Manager of Aims Biosciences, visited RMI’s Clinical Trials Unit (CTU) for monitoring, quality control, and audit of the ongoing trials. She was very impressed with the quality of work, ethical standards, and patient-centered approach of the CTU. Ms. Hui was received and briefed by […]

COVID-19 Booster Dose 

A Multi-center, Randomized, Blinded, Placebo-controlled, Phase 3 Clinical Study to Evaluate the Efficacy, Safety and Immunogenicity of SARS-CoV-2 Bivalent mRNA Vaccine (LVRNA021) as Booster in Participants Aged 18 Years and Older who Completed Primary/1 Booster Dose(s) of SARS-CoV-2 Vaccination Study Status: Recruitment Completed  Thanks to All the Participants and their families for the active participation […]

COVID-19 Treatment

A Phase 3, multicenter, randomized, double-blind, 48-week study of the clinical and antiviral effect of S 217622 compared with placebo in non-hospitalized high risk participants with COVID 19 Study Status: Recruitment started